Perspective Therapeutics Inc (AMEX:CATX) price closed lower on Tuesday, July 01, and dropping -4.65%...
B. Riley lifted their target price on Perspective Therapeutics from $9.00 to $12.00 and gave the com...
Perspective Therapeutics (NYSE:CATX – Get Free Report) and Bioventus (NYSE:BVS – Get Free Report) ar...
Perspective Therapeutics (NYSE:CATX – Get Free Report)‘s stock had its “outperform” rating reaffirme...